| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85483ac98517c2c3d67bb829aa5d816f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2018-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7296051b8dce77b13d0f8258c59e4132
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45100c45b641e563bb15258540435d0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a354f30766c1e22e8088e35ea9f825b9 |
| publicationDate |
2020-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3687496-A1 |
| titleOfInvention |
Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases |
| abstract |
The invention relates to a pharmaceutical composition for use in the prevention or treatment of glaucoma, an increase in intraocular pressure, an ocular hypertension and / or a symptom associated therewith, the composition comprising latanoprost and a liquid carrier comprising a semi-fluorinated alkane; the composition being administered at the eye of a patient; and the amount of latanoprost administered in a single dose per eye ranging from about 0.5 to 1.4 μg. |
| priorityDate |
2017-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |